Beernink JM, Jongs N, Mosterd CM, Scholtes RA, et al. Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial. Diabetes Obes Metab 2025 May 30. doi: 10.1111/dom.16478.
PMID: 40444388